Laurent Garderet

Laurent Garderet

UNVERIFIED PROFILE

Are you Laurent Garderet?   Register this Author

Register author
Laurent Garderet

Laurent Garderet

Publications by authors named "Laurent Garderet"

Are you Laurent Garderet?   Register this Author

96Publications

5052Reads

49Profile Views

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process.

TH Open 2019 Oct 4;3(4):e340-e347. Epub 2019 Nov 4.

Research Group "Cancer, Haemostasis and Angiogenesis," INSERM UMR_S 938, Centre de Recherche Saint-Antoine, Faculty of Medicine, Institut Universitaire de Cancérologie, Sorbonne Universities, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1700885DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828570PMC
October 2019

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Leukemia 2019 09 9;33(9):2324-2330. Epub 2019 Apr 9.

ProfilExpert, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0452-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756025PMC
September 2019

Systemic Dysfunction of Osteoblast Differentiation in Adipose-Derived Stem Cells from Patients with Multiple Myeloma.

Cells 2019 05 10;8(5). Epub 2019 May 10.

Sorbonne Université, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine-Team Proliferation and Differentiation of Stem Cells, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Département d'Hématologie et de Thérapie Cellulaire, F-75012 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells8050441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562713PMC
May 2019

Navigating the treatment landscape in multiple myeloma: which combinations to use and when?

Ann Hematol 2019 Jan 23;98(1):1-18. Epub 2018 Nov 23.

INSERM, UMR_S 938, Proliferation and Differentiation of Stem Cells, Paris, 75012, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3546-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334731PMC
January 2019

Prospective Evaluation of Magnetic Resonance Imaging and [F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.

J Clin Oncol 2017 Sep 7;35(25):2911-2918. Epub 2017 Jul 7.

Philippe Moreau, Florence Caillon, Caroline Bodet-Milin, Aurelie Gaultier, Jean-Michel Nguyen, Benoit Dupas, Eric Frampas, and Françoise Kraeber-Bodere, University Hospital, Nantes; Michel Attal, University Hospital, Toulouse; Denis Caillot, University Hospital, Dijon; Margaret Macro, University Hospital, Caen; Lionel Karlin, University Hospital, Lyon; Laurent Garderet, University Hospital Saint-Antoine, Paris; Thierry Facon, University Hospital, Lille; Lotfi Benboubker, University Hospital, Tours; Martine Escoffre-Barbe, University Hospital, Rennes; Anne-Marie Stoppa, Institut Paoli-Calmettes, Marseille; Kamel Laribi, University Hospital, Le Mans; Cyrille Hulin and Gerald Marit, University Hospital, Bordeaux; Aurore Perrot, University Hospital, Nancy; Jean-Richard Eveillard, University Hospital, Brest; Brigitte Pegourie, University Hospital, Grenoble; Veronique Dorvaux, University Hospital, Metz; Carine Chaleteix, University Hospital, Clermont-Ferrand; and Herve Avet-Loiseau, University Hospital, Toulouse, France; and Kenneth Anderson, Paul Richardson, and Nikhil C. Munshi, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2975DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578392PMC
September 2017

Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances.

Biol Blood Marrow Transplant 2017 Jul 8;23(7):1193-1202. Epub 2017 Mar 8.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.009DOI Listing
July 2017

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

N Engl J Med 2017 04;376(14):1311-1320

From the Institut Universitaire du Cancer de Toulouse-Oncopole (M.A., M.R., C.P., S.R., H.A.-L.) and Service d'Epidémiologie, Centre Hospitalier et Universitaire de Toulouse (V.L.-C.), Toulouse, Hôpital Haut-Lévêque, Bordeaux Pessac (C.H.), Centre Hospitalier et Universitaire la Miletrie, Poitiers (X.L.), Centre Hospitalier Le Bocage, Dijon (D.C.), Centre Hospitalier et Universitaire de Rennes, Rennes (M.E.), Hôpital St.-Louis (B.A., J.P.F.), Centre Hospitalier Universitaire, Hôpital St.-Antoine (L.G.), Institut Curie (C.M.), and Haute Autorité de Santé (J.-L.H.), Paris, Institut d'Hématologie de Basse Normandie, Centre Hospitalier et Universitaire de Caen, Caen (M.M.), Centre Hospitalier et Universitaire Henri Mondor, Creteil (K.B.), Hôpital Claude Huriez, Lille (T.F.), and Hôtel Dieu, Nantes (P.M.) - all in France; Institut Jules Bordet, Brussels (N. Meuleman); and Dana-Farber Cancer Institute, Boston (M.E.M., A.A.Z., E.A.W., N. Munshi, K.C.A., P.G.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1611750DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201242PMC
April 2017

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.

Haematologica 2016 11 9;101(11):1390-1397. Epub 2016 Sep 9.

INSERM, UMR_S 938, Proliferation and Differentiation of Stem Cells, AP-HP, Hôpital Saint Antoine, Département d'Hématologie et de Thérapie Cellulaire, F-75012, Paris, Université Pierre et Marie Curie-Paris 6, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.150334DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394878PMC
November 2016

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.

J Clin Oncol 2016 10;34(30):3609-3617

Cyrille Hulin, Bordeaux Hospital University Center, Bourdeaux; Philippe Rodon, Centre Hospitalier de Périgueux, Périgueux; Brigitte Pégourié, Centre Hospitalier Regional Universitaire, Grenoble; Laurent Garderet, Centre Hospitalier Universitaire (CHU) Hôpital St-Antoine, Paris; Isabelle Azais, CHU Institut National de la Santé et de la Recherche Médicale (INSERM); Xavier Leleu, Hôpital de la Milétrie, CHU INSERM, Poitiers; Margaret Macro, CHU de Caen, Caen; Bruno Royer, University Hospital, Amiens; Thierry Facon, Hôpital Claude Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France; Andrew Belch, Cross Cancer Institute, Edmonton, Alberta; Chaim Shustik, Royal Victoria Hospital; Richard LeBlanc, Hôpital Maisonneuve-Rosemont, Montreal, Quebec; Kevin Song, Vancouver General Hospital, Vancouver, British Columbia, Canada; Maria Teresa Petrucci, Azienda Policlinico Umberto I, University La Sapienza, Rome, Italy; Ulrich Dührsen, University Hospital of Essen, West German Cancer Center, Essen, Germany; Jin Lu, Peking University Institute of Hematology, People's Hospital, Beijing, China; Hannah Hunter, Derriford Hospital, Plymouth, United Kingdom; Richard Eek, Border Medical Oncology, Wodonga, Victoria, Australia; Heinz Gisslinger, Medizinische Universität Wien, Vienna, Austria; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Cristina Goncalves, Hospital de Santo Antonio-Porto, Porto, Portugal; Ken Romeril, Wellington Hospital, Wellington, New Zealand; Chantal Doyen, Université Catholique de Louvain (UCL), CHU UCL Namur, Yvoir; Fritz Offner, Universitair Ziekenhuis Gent, Ghent, Belgium; Nicolas Leupin, Celgene International, Boudry, Switzerland; Vanessa Houck, Guang Chen, and Annette Ervin-Haynes, Celgene, Summit, NJ; and Meletios A. Dimopoulos, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7295DOI Listing
October 2016

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.

J Clin Oncol 2016 06 25;34(18):2125-32. Epub 2016 Apr 25.

Bruno Royer, Momar Diouf, and Jean Pierre Marolleau, University Hospital, Amiens; Stéphane Minvielle and Philippe Moreau, University Hospital; Stéphane Minvielle, Institut National de la Santé et de la Recherche Médicale U892, Nantes; Murielle Roussel and Hervé Avet-Loiseau, Institute Universitaire du Cancer de Toulouse Oncopole; Hervé Avet-Loiseau, University Hospital, Toulouse; Lionel Karlin, University Hospital, Lyon; Cyrille Hulin, University Hospital, Vandœuvre lès Nancy; Bertrand Arnulf, St Louis University Hospital; Laurent Frenzel, Necker University Hospital; Laurent Garderet, St Antoine University Hospital; Sylvain Choquet, La Pitié University Hospital, Paris; Margaret Macro, University Hospital, Caen; Sylvie Cailleres, General Hospital, Aix en Provence; Annie Brion, University Hospital, Besançon; Sabine Brechignac, University Hospital, Bobigny; Karim Belhadj, University Hospital, Creteil; Marie Lorraine Chretien, University Hospital, Dijon; Marc Wetterwald, General Hospital, Dunkerque; Carine Chaleteix, University Hospital, Clermont-Ferrand; Mourad Tiab, General Hospital, La Roche/Yon; Xavier Leleu, University Hospital, Poitiers; Jean Gabriel Fuzibet, University Department, Nice; Charles Dauriac, University Hospital, Rennes; Luc-Matthieu Forneker, University Hospital, Strasbourg; Lotfi Benboubker, University Hospital, Tours; and Thierry Facon, University Hospital, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1929DOI Listing
June 2016

International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment.

J Clin Oncol 2016 05 14;34(13):1544-57. Epub 2016 Mar 14.

Meletios A. Dimopoulos, Efstathios Kastritis, and Evangelos Terpos, National and Kapodistrian University of Athens, Athens, Greece; Pieter Sonneveld, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Nelson Leung and S. Vincent Rajkumar, Mayo Clinic, Rochester, MN; Robert Z. Orlowski, The University of Texas MD Anderson Cancer Center, Houston, TX; David H. Vesole, Hackensack University Medical Center, Hackensack, NJ; Paul G. Richardson, Dana-Farber Cancer Institute, Boston, MA; Brian G.M. Durie, Samuel Oschin Cancer Center, Los Angeles, CA; Giampaolo Merlini, Scientific Institute Policlinico San Matteo and University of Pavia, Pavia; Antonio Palumbo, University of Torino, Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino, Torino; Michele Cavo, Bologna University School of Medicine, S.Orsola's University Hospital, Bologna, Italy; Heinz Ludwig, Wilhelminenspital, Vienna, Austria; Hartmut Goldschmidt, University Hospital and National Center for Tumor Diseases Heidelberg, Heidelberg; Hermann Einsele, Wuerzburg University Medical Center, Wuerzburg, Germany; Douglas Joshua, Royal Prince Alfred Hospital, Sydney University Medical School, Sydney, New South Wales, Australia; Raymond Powles, Cancer Centre London, London, United Kingdom; Laurent Garderet, Saint Antoine Hospital & University of "Pierre et Marie Curie" Paris-6, Paris; Philippe Moreau, University Hospital Hôtel-Dieu, Nantes, France; and Jesús San Miguel, Clínica Universidad de Navarra/CIMA, Navarra, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.0044DOI Listing
May 2016

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Apr;374(17):1621-34

From University Hospital Hôtel Dieu, Nantes (P.M., C.T.), the Department of Hematology, Institut Paoli-Calmettes, Marseille (A.-M.S.), and the Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris (L.G.) - all in France; the Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary (T.M.); the Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, and St. John's Cancer Center, Lublin, Poland (N.G.); Southern Alberta Cancer Research Institute, University of Calgary, Calgary (N.J.B.), and the Division of Hematology, Department of Medicine, University of Alberta, Edmonton (I.S.) - both in Canada; the Department of Hematology, Skåne University Hospital, Lund University, Lund, Sweden (M.H.); Hematology and Oncology, University Hospital Brno, Brno, Czech Republic (L.P.); the Department of Haematology, Christchurch Hospital, Christchurch (P. Ganly), the Department of Haematology, Palmerston North Hospital, Palmerston North, Manawatu (B.W.B.), the Department of Haematology, Middlemore Hospital, Auckland (S.R.J.), and the Department of Haematology, North Shore Hospital, Auckland (D.R.S.) - all in New Zealand; the Department of Hematology, University Hospital Rigshospitalet, Copenhagen (P. Gimsing); Myeloma Unit, Division of Hematology, University of Turin, Turin (A.P.), and Seràgnoli Institute of Haematology, Bologna University School of Medicine, St. Orsola-Malpighi University Hospital, Bologna (M.C.) - both in Italy; the Division of Hematology, Mayo Clinic, Rochester, MN (S.K., F.K.B.); and Dana-Farber Cancer Institute, Boston (J.P.L., P.G.R.), and Millennium Pharmaceuticals, Cambridge (D.T.B., J.L., A.D.B., A.-M.H., H.V.) - both in Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1516282DOI Listing
April 2016

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Biol Blood Marrow Transplant 2015 Dec 30;21(12):2039-2051. Epub 2015 Sep 30.

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757494PMC
December 2015

Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.

Br J Haematol 2015 Nov 27;171(4):453-62. Epub 2015 Jul 27.

Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation (EBMT), Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13608DOI Listing
November 2015

Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain.

Medicine (Baltimore) 2015 Aug;94(32):e1247

From the AP-HP (AA-F, BF), Hôpital Saint Antoine, Department of Pathology, Paris; CNRS UMR 7276 Université de Limoges (SB, MCV), Hôpital Universitaire Dupuytren; AP-HP (DB), Hôpital Tenon, Department of Pathology, Paris; Université Pierre et Marie Curie-Paris 6 (DB), Paris; Centre hospitalier de Troyes (SB), Service D'Hématologie; AP-HP (MM), Hôpital Saint-Antoine, Service d'Hématologie Clinique et Thérapie Cellulaire, Paris; Université Pierre & Marie Curie (MM), Paris; INSERM (MM), UMRs, U938, Paris; AP-HP (PR, JJB), Hôpital Tenon, Department of Nephrology and Dialysis, Paris; Sorbonne Universités (PR, JJB), UPMC Univ Paris 06, UMR_S 1155; INSERM (PR, JJB), UMR_S 1155, Paris; INSERM (PA), UMRS 938, Hôpital Saint-Antoine, Paris; Université Pierre et Marie Curie-Paris6 (PA), Hôpital Saint-Antoine, Paris; INSERM (LG), UMR_S 938, Paris; AP-HP (LG), Hôpital Saint Antoine, Département d'hématologie et de thérapie cellulaire, Paris; and Université Pierre et Marie Curie-Paris6 (LG), Paris, France.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00005792-201508020-000
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000001247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616688PMC
August 2015

Efficacy of imatinib mesylate in a case of Churg-Strauss syndrome: evidence for the pathogenic role of a tyrosine kinase?

Rheumatology (Oxford) 2014 Feb 27;53(2):378-9. Epub 2013 Jul 27.

Department of Internal Medicine, Hospital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ket261DOI Listing
February 2014

Administration of alemtuzumab and G-CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study.

Eur J Haematol 2013 Oct 28;91(4):315-21. Epub 2013 Aug 28.

Department of Hematology and Cell Therapy, Hopital Saint-Antoine, Assistance Publique-Hopitaux de Paris, and University UPMC, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12154DOI Listing
October 2013

Multiplexed infectious protein microarray immunoassay suitable for the study of the specificity of monoclonal immunoglobulins.

Anal Biochem 2013 Feb 26;433(2):202-9. Epub 2012 Oct 26.

INSERM UMR892/CNRS UMR6299, Institut de Recherche Thérapeutique, Université de Nantes, 44007 Nantes Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ab.2012.10.012DOI Listing
February 2013

An unexpected trismus.

Lancet 2012 Aug;380(9840):536

Medical Intensive Care Unit, Hospital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(12)60524-8DOI Listing
August 2012

[Treatment of myeloma in the elderly].

Bull Cancer 2008 May;95 FMC Onco:F84-8

Hôpital Saint-Antoine, service d'hématologie et de thérapie cellulaire, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2007.0548DOI Listing
May 2008

Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib.

Haematologica 2007 Jan;92(1):e9-10

Department of Hematology, Saint Antoine Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.10935DOI Listing
January 2007

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

Blood 2005 Aug 28;106(4):1376-81. Epub 2005 Apr 28.

Department of Clinical Hematology, H. Mondor Hospital, Paris XII University, Assistance Publique-Hôpitaux de Paris, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-01-0272DOI Listing
August 2005

A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation.

Blood 2002 Feb;99(4):1458-64

Laboratoire d'Immunologie et d'Histocompatibilité, INSERM U.396, Institut Universitaire d'Hématologie; Service d'Hématologie-Greffe de Moelle, Hôpital Saint-Louis, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v99.4.1458DOI Listing
February 2002